← Back to news
NewsFRONTIERS IN IMMUNOLOGYFriday, February 20, 2026 · February 20, 2026

Myelodysplastic syndrome progress to acute myeloid leukemia: new insights and updates.

WHY IT MATTERS

Recent peer-reviewed research on Myelodysplastic syndrome that may be relevant for patients and caregivers.

The progression of myelodysplastic syndromes (MDS) to secondary acute myeloid leukemia (sAML), classified under AML with myelodysplasia-related changes (AML-MRC), is a multi-step process driven by the dynamic interplay between cell-intrinsic genetic events and extrinsic microenvironmental remodeling...

Read on PubMed
Read the original at Frontiers in immunology
ResearchPubMedMyelodysplastic syndromeHumansMyelodysplastic Syndromes

Related conditions

Myelodysplastic syndrome

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.